23
Views
91
CrossRef citations to date
0
Altmetric
Article

Proteomic Identification of Desmoglein 2 and Activated Leukocyte Cell Adhesion Molecule as Substrates of ADAM17 and ADAM10 by Difference Gel Electrophoresis

, , , , , & show all
Pages 5086-5095 | Received 14 Dec 2005, Accepted 07 Apr 2006, Published online: 27 Mar 2023

REFERENCES

  • Annaert, W., and B. De Strooper. 2002. A cell biological perspective on Alzheimer's disease. Annu. Rev. Cell Dev. Biol. 18:25–51.
  • Arribas, J., and A. Borroto. 2002. Protein ectodomain shedding. Chem. Rev. 102:4627–4638.
  • Baker, A. H., D. R. Edwards, and G. Murphy. 2002. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115:3719–3727.
  • Balbin, M., A. Fueyo, A. M. Tester, A. M. Pendas, A. S. Pitiot, A. Astudillo, C. M. Overall, S. D. Shapiro, and C. Lopez-Otin. 2003. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet. 35:252–257.
  • Baselga, J., and C. L. Arteaga. 2005. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer J. Clin. Oncol. 23:2445–2459. (Erratum, 23:6281.)
  • Blobel, C. P. 2005. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell. Biol. 6:32–43.
  • Boire, A., L. Covic, A. Agarwal, S. Jacques, S. Sherifi, and A. Kuliopulos. 2005. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120:303–313.
  • Borrell-Pagès, M., F. Rojo, J. Albanell, J. Baselga, and J. Arribas. 2003. TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J. 22:1114–1124.
  • Borroto, A., S. Ruiz-Paz, T. Villanueva de la Torre, M. Borrell-Pages, A. Merlos-Suarez, A. Pandiella, C. P. Blobel, J. Baselga, and J. Arribas. 2003. Impaired trafficking and activation of TACE in cell mutants defective in protein ectodomain shedding. J. Biol. Chem. 278:25933–25939.
  • Buxbaum, J. D., K. N. Liu, Y. Luo, J. L. Slack, K. L. Stocking, J. J. Peschon, R. S. Johnson, B. J. Castner, D. P. Cerretti, and R. A. Black. 1998. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273:27765–27767.
  • Coughlin, S. R. 2000. Thrombin signalling and protease-activated receptors. Nature 407:258–264.
  • Coussens, L. M., B. Fingleton, and L. M. Matrisian. 2002. Matrix metalloproteinase inhibitors and cancer—trials and tribulations. Science 295:2387–2392.
  • Dassler, K., M. Kaup, R. Tauber, and H. Fuchs. 2003. Mutational suppression of transferrin receptor shedding can be compensated by distinct metalloproteases acting on alternative sites. FEBS Lett. 536:25–29.
  • Dong, J., L. K. Opresko, P. J. Dempsey, D. A. Lauffenburger, R. J. Coffey, and H. S. Wiley. 1999. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA 96:6235–6240.
  • Fortini, M. E. 2002. Signalling: gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat. Rev. Mol. Cell. Biol. 3:673–684.
  • Franco, S. J., and A. Huttenlocher. 2005. Regulating cell migration: calpains make the cut. J. Cell Sci. 118:3829–3838.
  • Getsios, S., A. C. Huen, and K. J. Green. 2004. Working out the strength and flexibility of desmosomes. Nat. Rev. Mol. Cell. Biol. 5:271–281.
  • Guo, L., J. R. Eisenman, R. M. Mahimkar, J. J. Peschon, R. J. Paxton, R. A. Black, and R. S. Johnson. 2002. A proteomic approach for the identification of cell-surface proteins shed by metalloproteases. Mol. Cell Proteomics 1:30–36.
  • Kaup, M., K. Dassler, C. Weise, and H. Fuchs. 2002. Shedding of the transferrin receptor is mediated constitutively by an integral membrane metalloprotease sensitive to tumor necrosis factor alpha protease inhibitor-2. J. Biol. Chem. 277:38494–38502.
  • Krätzschmar, J., L. Lum, and C. P. Blobel. 1996. Metargidin, a membrane anchored metalloproteases-disintegrin protein with an RGD integrin binding sequence. J. Biol. Chem. 271:4593–4596.
  • Lopez-Otin, C., and C. M. Overall. 2002. Protease degradomics: a new challenge for proteomics. Nat. Rev. Mol. Cell. Biol. 3:509–519.
  • Lorch, J. H., J. Klessner, J. K. Park, S. Getsios, Y. L. Wu, M. S. Stack, and K. J. Green. 2004. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J. Biol. Chem. 279:37191–37200.
  • Marambaud, P., J. Shioi, G. Serban, A. Georgakopoulos, S. Sarner, V. Nagy, L. Baki, P. Wen, S. Efthimiopoulos, Z. Shao, T. Wisniewski, and N. K. Robakis. 2002. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21:1948–1956.
  • Mott, J. D., and Z. Werb. 2004. Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16:558–564.
  • Overall, C. M., and C. Lopez-Otin. 2002. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer 2:657–672.
  • Sahin, U., G. Weskamp, K. Kelly, H. M. Zhou, S. Higashiyama, J. Peschon, D. Hartmann, P. Saftig, and C. P. Blobel. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164:769–779.
  • Shevchenko, A., M. Wilm, O. Vorm, and M. Mann. 1996. Mass spectrometric sequencing of proteins on silver-stained polyacrylamide gels. Anal. Chem. 68:850–858.
  • Swart, G. W. M. 2002. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. Eur. J. Cell Biol. 8:313–321.
  • Tam, E. M., C. J. Morrison, Y. I. Wu, M. S. Stack, and C. M. Overall. 2004. Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl. Acad. Sci. USA 101:6917–6922.
  • Van den Bergh, G., and L. Arckens. 2004. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr. Opin. Biotechnol. 15:38–43.
  • Villanueva de la Torre, T., J. J. Bech-Serra, S. Ruiz-Paz, J. Baselga, and J. Arribas. 2004. Inactivating mutations block the tumor necrosis factor-alpha-converting enzyme in the early secretory pathway. Biochem. Biophys. Res. Commun. 314:1028–1035.
  • Yarden, Y., and M. X. Sliwkowski. 2001. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2:127–137.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.